Clinical Trials on Malignant Peripheral Nerve Sheath Tumors
Total 9631 results
-
University of Kansas Medical CenterCompletedMalignant MelanomaUnited States
-
University of BaselUniversity Hospital, Basel, SwitzerlandCompletedMalignant Melanoma
-
CelgenePrologue Research InternationalCompleted
-
Eli Lilly and CompanyCompletedMalignant MelanomaUnited States
-
Milton S. Hershey Medical CenterCompletedMalignant MelanomaUnited States
-
Skin Analytics LimitedCompleted
-
University of ArizonaTerminatedMalignant MelanomaUnited States
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownMalignant MelanomaChina
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Hoffmann-La RocheCompleted
-
University of California, DavisCompletedMelanoma | Malignant MelanomaUnited States
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
University Hospital TuebingenGerman Research FoundationCompleted
-
AstraZenecaCompleted
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
SentoClone ABUnknownMalignant MelanomaSweden
-
Royal Marsden NHS Foundation TrustUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Charles University, Czech RepublicCompletedVestibular Schwannoma | Vestibular Function DisorderCzechia
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
First Affiliated Hospital of Zhejiang UniversityRecruiting
-
Fudan UniversityRecruitingMalignant MelanomaChina
-
Massachusetts General HospitalDana-Farber Cancer InstituteRecruiting
-
ImmVira Pharma Co. LtdSuspendedMelanoma | Malignant MelanomaUnited States
-
Regeneron PharmaceuticalsCompleted
-
Aarhus University HospitalCompletedMalignant MelanomaDenmark
-
Prof. Dr. med. Dirk SchadendorfCompletedMalignant MelanomaGermany
-
The Christie NHS Foundation TrustCancer Research UK; Christie Charitable FundsCompleted
-
Prof. Dr. med. Dirk SchadendorfCompleted
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Timmune Biotech Inc.The Second Affiliated Hospital of Hainan Medical University; Hainan Cancer...Unknown
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Inge Marie SvaneCopenhagen University Hospital at HerlevTerminated
-
American Regent, Inc.CompletedMalignant MelanomaUnited States
-
Bristol-Myers SquibbTerminatedMalignant MelanomaGermany, United States, Mexico, Denmark, France, Belgium, United Kingdom, Spain
-
Scancell LtdTerminated
-
Hoffmann-La RocheCompleted
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Genentech, Inc.Terminated
-
Hoffmann-La RocheCompleted
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
Hoffmann-La RocheCompleted
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Oslo University HospitalCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance